africa pharma conference 2020...2020/04/01 · (auc), and key stakeholders including the consortium...

PHARMA

PHARMA

PHARMA

PHARMAPHARMA

PHARMA

LPPEssential MedicinesAPIFINANCINGR+DRegualators Quality Quality

LPPEssential Medicines

APIFINANCINGR+DRegualators Quality Quality


africa Pharmaconference 2020Enabling REgional Hubs foR incREasEd accEss to PHaRma and HEaltH commoditiEs

Date: June 8th - 10th, 2020 | Venue: RaDisson Blu hotelnaiRoBi uPPeR hillKenya

: [email protected]

: dfsafrica_ : Africa_dfs : DFSAfrica

Hosted By:

: AUDA NEPAD : AUDA_NEPAD

: NEPAD_Agency : AUDA_AGENCY

www.africapharmaconf.com

SPonSorShiP information Pack

3 AFRICA PHARMA CONFERENCE 2020 SPONSORSHIP INFORMATION PACK |www.africapharmaconf.com

DEAR PARTNER

You are cordially invited to participate as a sponsor of the Africa Pharma Conference 2020 which will hold at the Radisson Blu Hotel, Nairobi Upper Hill, Kenya on Monday 8th to Wednesday 10th June, 2020.

Following the successful Africa Pharma Conference 2019 held in Johannesburg, the 2020 conference promises to be even more informative and a critical hub of ideas and solutions to grow the Africa Pharma sector. This Africa Pharma Conference creates an avenue for Industry leaders, Public Authorities, Policy Makers, Project Sponsors, Fund managers, HNIs and investors in Pharma and Healthcare to come together to discuss best practices and the most efficient ways to scale Pharma production, structure healthcare projects and funnel private finance into the healthcare sector across Africa. The 2020 event will focus exclusively on conversations and solutions for “Enabling Regional Hubs for Increased Access to Pharma and Health Commodities”.

Sponsorship of the Africa Pharma Conference will provide your company with unparalleled visibility across all 55 countries in Africa, and within Africa’s investor universe, alongside providing broad networking opportunities and valuable business development insights into Africa’s Pharma and Healthcare sector.

There are various opportunities for Sponsors and Partners to be a part of the Africa Pharma Conference 2020 and this Sponsorship brief lists all the areas ranging from Platinum Sponsorship, Gold Sponsorship to sponsoring the Investment Deal Room, Executive Roundtables, Boot camp to name just a few.

The geographical focus of DFS Africa attracts companies from all parts of Africa, including North, East Southern and West Africa with companies from over 45 different African countries expected to attend in 2020. This document demonstrates the exciting benefits that you will enjoy as a sponsor and partner in making this event possible.

I look forward to liaising with you about how we can work together to grow the Africa Pharma industry.

Best regards,

Bankole EniolaCo-Founder & Chief Engagement Officer

AFRICA PHARMA CONFERENCE 2020

8th - 10th jUNE

Register today on www.africapharmaconf.com

Enabling Regional Hubs for Increased Access to Pharma and Health Commodities

Radisson Blu HotelNairobi Upper hill

Kenya

4 5 | AFRICA PHARMA CONFERENCE 2020 SPONSORSHIP INFORMATION PACK AFRICA PHARMA CONFERENCE 2020 SPONSORSHIP INFORMATION PACK |www.africapharmaconf.com www.africapharmaconf.com

ABOUT THE AFRICA PHARMA CONFERENCE 2020

The African Union Development Agency (AUDA-NEPAD), the African Union Commission (AUC), and key stakeholders including the Consortium of Partners (in support of the PMPA) are convening the Africa Pharma Conference in Nairobi (2020) to focus on issues and policies that will facilitate sustainable development of regional hubs in best practices. Ideas and initiatives around regional hubs will be explored and this will establish the foundation required for increased access to financial investments, technology and cross-continental capacity development for the pharmaceutical sector and allied ecosystem. The pharmaceutical industry in Africa is one of the fastest growing in the world. Over the past ten years, the market has exploded to US$ 21 Billion, with projected estimate of US$60 Billion by the end of 2020; hence a focus on building regional hubs that will accelerate the growth of the Africa Pharma industry is imperative.

The aim of the conference is to facilitate improved access to affordable essential medicines and catalyse local production in Africa through increased political commitments and workable solutions.

The conference will:

• Examine the evidence as it relates to constraints, opportunities and examples of good practices;

• Explore and showcase how regional hubs can drive further industrialisation and accelerate the growth of Africa’s supply chains for all essential medicines

• Consider a broad range of related issues including those of harmonization of regulatory protocols, research and development, production, quality control, distribution, testing and diagnosis and health care capacity development, as well as incentives that can boost local production on the African continent such as the African Medicines Agency, the African Continental Free Trade Area (AfCFTA) and other health systems initiatives;

• Facilitate and forge business to business partnerships;

• Articulate a set of recommended actions; The outcomes of the forum will be presented to African Union Organs such as the Assembly of Heads of State and Government for consideration.

ABOUT

Pharma Manufacturing Devices Pharma & Healthcare Financing

Health Technology

+

TOPICAL PARTICIPANTSCOUNTRy PARTICIPANTs

55African

Countries

DELEGATEs

12Other

Countries

326African

Delegates

INvEsTMENT DEAL ROOM

12Investors

38Investees

(Local Pharma Companies)

INDUsTRy

DELEGATE ROLEs

22Pharma CEOs &

Senior Executives

196Local Pharma Reps

74Government officials

44Multilaterals & Development

Agencies

25Investors & DFIs

32Academics & Researchers

42NGOs and Civil

Societies

15Media & Press

124Other

Delegates


Many leading organisations continue to play major roles in addressing the various developmental challenges faced by Africa. The Africa Pharma Conference provides a unique opportunity to showcase your organisation’s support and effort towards advancing Africa’s development.

We are offering limited sponsorship opportunities for companies like yours that we believe are a good fit for our audience. The Africa Pharma Conference is an opportunity to showcase how your organisation is contributing to Africa’s development.

sPONsORsHIP OPTIONs

PLATINUM SPONSORSHIP - $45,000 (Limited to 1 sponsor)• Event name attachment e.g. ‘Platinum Sponsor for Africa Pharma Conference 2020) • 5 Conference passes for your team • Conference website updated with brand logo (on every page) and hyperlink to your website. • Full Page advert in Conference Brochure (Inside front cover or inside back page) • Logo on Conference Bags - Position your company as an industry leader in front of the

whole Pharma industry and senior policy makers. Visitors will use these throughout the conference days to carry all their event information and promotional items, giving your brand ultimate visibility.

• Logo on Lanyards – Your company logo will be printed on lanyards. This will give maximum visibility of your brand because every attendee will wear them for the duration of the exhibition.

• Logo on all banners and digital displays on site • Free Standing Sign / Banners Outside Halls • Company flyers in conference bags or on seats• Access to Executive Boardroom sessions (2 Senior Executives from your team)

GOLD SPONSORSHIP - $30,000 (Limited to 1 sponsor)• Gold Sponsor label on website and all printed materials• 3 Conference passes for your team • Conference website updated with brand logo (on every page) and hyperlink to your website. • Full Page advert in Conference Brochure (page location decided by organisers)• Logo on all banners and digital displays on site • Free Standing Sign / Banners Outside Halls• Company flyers in conference bags or on seats• Access to Executive Boardroom sessions (1 Senior Executive from your team)

SPONSORSHIP OPPORTUNITIESKNOWLEDGE SESSIONS SPONSORS - $25,000 (Limited to 4 Sponsors) • Knowledge Sponsor label on website and all printed materials• Own a thematic session in line with Conference Concept Notes (see Appendix). Opportunity

to shape agenda and output of conference • 2 Conference passes • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • 1-page article in conference brochure• Access to Executive Boardroom sessions (1 Senior Executive from your team)

DEAL ROOM SPONSOR - $25,000 (Limited to 1 sponsor) • Event Track name attachment e.g. ‘Africa Pharma Deal Room 2020 in partnership with X

Company’ • Speaking slot at one of the Finance & Investment discussion tracks• 2 Conference passes • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • 1-page article in conference brochure• Access to Executive Boardroom sessions (1 Senior Executive from your team)

BOOT CAMP & LEARNING STATIONS SPONSOR - $20,000 (Limited to 1 Sponsor) • Event Track name attachment e.g. ‘Africa Pharma Conference Bootcamp in partnership

with X Company’ • Speaking slot at one of the Knowledge Transfer / Capacity Building discussion tracks • 2 Conference passes • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • Half Page advert in Conference Brochure • Access to Executive Boardroom sessions (1 Senior Executive from your team)

REGISTRATION SPONSORS - $15,000 (Limited to 1 Sponsor) • 2 conference passes • Co-Branded Show Bags - Position your company as an industry leader in front of the

whole Pharma industry and senior policy makers. Visitors will use these throughout the conference days to carry all their event information and promotional items, giving your brand ultimate visibility.

• Logo on Lanyards - Your company logo will be printed on lanyards. This will give maximum visibility of your brand because every attendee will wear them for the duration of the exhibition.


• Branding by Registration Desk • Flyers in Conference Bag • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • Half Page advert in Conference Brochure

COUNTRY SESSION SPONSORS - $7,500 (Limited to 5 Countries)• 2 conference passes• 15 min Speaking slot on country – topic aligned to Concept Note (see Appendix)• Flyers/brochure in Conference Bags • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • Half Page advert in Conference Brochure • 1-page article in conference brochure

PRE-EVENT COCKTAIL SPONSORSHIP (holds on June 8th 2020) - $10,000 (Limited to 1 Sponsor)• Event Track name attachment e.g. ‘Africa Pharma Conference Welcome Cocktail sponsored by X

Company’ • 10 mins Speaking slot at the cocktail event• 2 Conference passes • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • Half Page advert in Conference Brochure

POST-EVENT DINNER FOR HIGH LEVEL DELEGATES (holds on June 10th 2020) - $12,500 (Limited to 1 Sponsor)• Event Track name attachment e.g. ‘Africa Pharma Conference VIP Dinner sponsored by X Company’ • Speaking slot at one of the Knowledge Transfer / Capacity Building discussion tracks • 2 Conference passes • Conference website updated with brand logo (on every page) and hyperlink to your website. • Logo on all banners and digital displays on site • Half Page advert in Conference Brochure • Access to Executive Boardroom sessions (1 Senior Executive from your team)

OTHER PROMOTIONAL OPPORTUNITIES (Multiple Sponsors)• Brochure Advert (full page) - $3,500• Flyers included in Conference Bags, Registration Desk and all seats - $5,000

PHARMA

PHARMA

PHARMA

PHARMAPHARMA

PHARMA


LPPEssential Medicines

APIFINANCINGR+DRegualators Quality Quality


APPENDIX


CONTEXT

African leaders seek to facilitate the creation of an enabling environment where every person has the opportunity to optimize their development potential. As the continent continues to grow such opportunities across several fronts, challenges remain to be fully surmounted in a host of key sectors. Health status of Africans remain sub-optimal and the health care delivery systems at national level are yet to be as efficient and accessible as required to provide for the

sustainable delivery of testing, diagnostic, treatment and support services to the highest attainable standard of health.

The continent bears a significant burden of infectious diseases and non-communicable diseases, with huge unmet needs for Family Planning and other Reproductive Health commodities. Outbreaks of emerging infectious diseases such as the recent Ebola pandemic have further underscored the need to respond rapidly. Access to medicines for many infectious and non-communicable diseases, nevertheless remains low across Africa in addition to weaknesses in the supply chain systems.

This creates an opportunity for pharmaceutical companies (and allied firms) to increase their presence and partner with local manufacturing companies to gain access into the market and expand their activities, while national governments reduce their dependency on donors and facilitate a more secure supply of these essential products.

The Africa Pharma Conference in Nairobi (2020) will focus on ideas and initiatives for growing Pharmaceutical regional hubs which will facilitate increased access to financial investments, technology and cross-continental capacity development for the pharmaceutical sector and allied ecosystem. The pharmaceutical industry in Africa is one of the fastest growing in the world. In past ten years the

market has exploded to US$ 21 Billion, with projected estimate of US$60 Billion by the end of 2020; hence the focus on building regional hubs that will accentuate the growth of the African market is imperative.

Rapid urbanisation and increase in lifestyle diseases is another reason why regional hubs are crucial to Africa’s desire to catalyze local manufacturing of essential medicines. As discretionary incomes continue to rise across Africa, there will be a need to expand healthcare, governments’ incentives in healthcare, access to prescription and availability of generic medicine and medical devices. The smartest way for African communities to understand, analyse and catalyze this

CONCEPT NOTESprojected growth will be through the prism of regional and local needs and solutions. This desire to optimize Africa’s pharmaceutical ecosystem through regional development, will not be possible if challenges such as policy and regulation incoherence, shortage of specialists, weak quality regulatory agencies and fragmented markets are not addressed.

African leaders have previously established political commitments, including the Pharmaceutical Manufacturing Plan for Africa and its related Business Plan, the African Medicines Regulatory Harmonization (AMRH) Programme led by the NEPAD Planning and Coordinating Agency, and the AU Roadmap on Global Solidarity and Shared Responsibility. Furthermore, the continents leaders are firmly committed to industrial development as articulated in the AU Accelerated Industrial Development Plan for Africa (AIDA). These need to be fully developed and implemented.

It is therefore imperative that the continent streamline and harmonize local and regional regulations, integrate markets, incentivize business environment to facilitate the operation of potential investors. This fits well within the framework of the Action Plan for the Accelerated Industrial Development of Africa (AIDA) which seeks to facilitate an acceleration of industrial development (on the continent) and diversification of the economy to meet the challenges of (sustainable) development.

Experience and knowledge need to be shared between countries, within industries, and across the range of stakeholders. The challenges and opportunities need to be identified and addressed, and the political commitment across the continent harnessed in a structured manner. Private sector actors including finance institutions, health care service providers and (international and local) pharmaceutical manufacturers (including medical devices and diagnostics) must develop mutually beneficial partnerships

In September 2017, African Union leaders, UN Principals, representatives of international finance institutions and private sector actors reaffirmed their commitment to a broad-based international partnership to industrialize Africa in a socially inclusive and environmentally sustainable manner through the UN General Assembly’s declaration of 2016-2025 as the Third Industrial Development Decade for Africa (IDDA III).

Consequently, the African Union Development Agency (AUDA-NEPAD), African Union Commission (AUC), and key stakeholders including the Consortium of Partners (in support of the PMPA) will convene annually for the Africa Pharma Conference. This conference is a high-level, pan-African forum on improving access to essential medicines and facilitating local production. The inaugural session of the conference was held in Johannesburg South Africa in June 2019 where, amongst other recommendations, AUC, NEPAD, RECs and FAPMA agreed to implement concrete strategies and policies that will ensure that African Pharma companies supply at least 50% of the essential medicines requirements within a decade.


To this end, the Africa Pharma Conference 2020 will focus on establishing clear priorities for specific, coordinated and effective actions as well as Business-to-Business Platforms with support and commitment of senior policy makers to realize the vision of the African Heads of State and Government and enable Regional Economic Communities in increasing access to Pharmaceuticals and health commodities. The second edition of the Africa Pharma Conference will take place in Nairobi on the 8th to 10th of June 2020.

OBJECTIvEs

The overall aim of the conference is to facilitate concrete actions that will improve universal access to quality- assured affordable essential medicines and catalyze local production in Africa by harnessing high-level political commitment and workable solutions.

The forum will;• Examine the evidence as it relates to constraints

and how to overcome them, opportunities and propose a number of concrete steps that can be implemented by governments to develop LPP;

• Consider a broad range of related issues including those of harmonization of regulatory protocols, research and development, production, quality control, distribution, testing and diagnosis and health care capacity development, as well as incentives that can boost local production on the African continent such as the African Medicines Agency and other health systems initiatives;

• Examine the way global pharmaceutical companies can partner with African LPP’s to share knowledge, capacity development, technology and financing;

• Facilitate and forge business to business partnerships; • Seek to support African Regional Economic Communities and countries to craft strategies

that ensures increased access to Pharmaceuticals and health commodities; • Discuss existing best practices employed by successful hubs for increased access to

pharmaceuticals and how less successful hubs can leverage; • Articulate a set of recommended actions;

The outcomes of the forum will be presented to the African Union Organs, such as the Assembly of Heads of State and Government for consideration.

DELIvERABLEs

These will include:I. Unified African leadership, working with pharmaceutical companies, business leaders and

other stakeholders towards establishing a viable African pharmaceutical industry.II. Enhanced understanding of short- and longer-term opportunities for cost reductions,

through procurement practices in order to ensure affordable and sustainable supplies of essential medicines.

III. Identification of opportunities to expand national and regional capacity to scale up pharmaceutical manufacturing across Africa through:

i. Improved procurementii. Innovative service deliveryiii. Expanded research and development, andiv. Streamlined, coordinated and cooperative regulatory capabilities’v. Appropriate financial incentives and tax options;

IV. Strengthened platforms for Triangular collaboration (North-South and South-South) as well as Business to Business partnerships.

PARTICIPATION

Participants and delegates to the Conference will include;

i. Heads of Stateii. Senior Government Officials such as Line Ministers; (Health,

Industry, Trade, Finance etc.);iii. Regional Economic Communities (RECs) i.e. ECOWAS,

SADC, COMESA, AMU, EAC, ECCAS,iv. Private Sector – Pharmaceutical companies, Pharmaceutical

trade associations (e.g. FAPMA, IFPMA) and companies, Medical Device and Diagnostics manufacturers; Investment and Finance Institutions; Logistics firms; etc.

v. USP / USAIDvi. Global Public Health institutions (Global Fund,

PEPFAR, UNITAID, MPP etc.)vii. National Medicines Regulatory. Authorities,viii. United Nations Agencies;ix. African Academic and Research Institutions;x. Civil Society;xi. Donors and Development partners;xii. Regional and International Finance

Institutions


AGENDA

The high level conference will run for three (3) days and the agenda will address amongst others;1. Policy coherence (across sectors),2. Health Sector Imperatives such as Universal Health

Coverage (UHC), Maternal and Child Health,3. African Medicines Agency (AMA) and Regulation,4. Market Integration,5. Volume guarantees and Incentives,6. Good Manufacturing Practices (GMP),7. Medical Devices and allied products,8. Leveraging technology and artificial intelligence,9. Pharmaceutical Financing Strategy,10. Catalyzing Research and Development (R &D),11. Strengthening Market Intelligence and

Evidence Base,12. Supply Chain Management System

(SCMS),13. Business facilitation and Investment

Promotion,14. TRIPS Flexibilities,15. Africa CDC and Humanitarian context16. Leveraging the African Diaspora,17. South-South and Triangular Cooperation,18. Infrastructure and multi-sectoral factors, including human resources development;

METHODOLOGy

The Conference will be organised to include didactic technical sessions; high level plenary sessions as well as focused thematic events.

DATE AND vENUE

Date: 8th to 10th of June 2020

Venue: Radisson Blu Hotel Nairobi Upper Hill Kenya

DOCUMENTATION

Reference documents – will include but not limited to;1. Situational analysis of current practices in ensuring affordable and sustainable drug supply

across Africa, focusing on challenges and best practices, including incentive package to boost private sector investment;

2. Policy briefs on selected interventions that promote local production;3. Synopsis on the Business Plan of the PMPA Summary reports of related research and

generated evidence;4. Business Plan for the operationalisation of the Pharmaceutical Manufacturing Plan for

Africa;5. Background document on Establishment of Fund for African Pharmaceutical Development;6. Action Plan for the Accelerated Industrial Development of Africa (AIDA);7. Declaration of UN General Assembly on Third Industrial Development Decade for Africa

(IDDA III);

1. DEAL ROOM:

The Deal Room at APC 2020 will connect African pharmaceutical manufacturing and packaging companies to a global pool of financing organizations that include; Impact Investors, Private Equity Funds, Investment companies and Development Finance Institutions (DFIs). The model of the Deal Room is to match vetted, relevant and development-focused high growth Pharma businesses in Africa to the right partnerships that can help them to scale; thereby providing the right financing, technological and capacity development support.

2. BOARD ROOM:

The Board Room at APC 2020 is a 2-hour session that brings together 12-14 principal stakeholders within the Pharma ecosystem to deliberate on critical topics affecting the pharma value chain. Each board room session will consist of the following stakeholders: Minister of Health/Finance/Trade [Governments], Top executive of a Big-Pharma company, Investors, Research and development, Local manufacturers, Key Opinion Leaders, Technology providers and Media. This is an invite only session.

3. BOOT CAMP:

The Boot Camp at APC 2020 will hold for two days preceding the conference. The boot camp will be in partnership with Wharton Business School, WHO and UNICEF. The training sessions will focus on equipping the participants (LPPs) with critical skills required in the Pharma value chain. Some of the topics to be considered during the APC 2020 boot camp will include: Procurement, Supply chain, creating lean and efficient business models etc. Participants of the boot camp will be awarded a certificate of participation at the end of the boot camp.

sIDE EvENTs

The Conference will be organised in parallel to the following side events:

16 | AFRICA PHARMA CONFERENCE 2020 SPONSORSHIP INFORMATION PACK www.africapharmaconf.com

8. Cairo Declaration in Viral Hepatitis9. Strengthening Pharmaceutical Innovation in Africa - Designing strategies for national

pharmaceutical innovation: choices for decision makers and countries include more documentation on regional hubs if possible so that we have the theme well covered all through the Conference

WORKING LANGUAGEs

English and French will be the working languages of the conference.

FOR FURTHER INFORMATION, PLEAsE CONTACT

1. Dr Janet Byaruhanga; Senior Program Officer; NEPAD; [email protected]

2. Dr. Djoudalbaye Benjamin; Head of Policy and Health Diplomacy at Africa Centres for Disease Control and Prevention; AUC

[email protected]

3. Mr Bankole Eniola; Executive Director, DFS Africa; [email protected]

DFsADVISORYSERVICES

DFS Africa is a platform dedicated to connecting projects and businesses in Africa to the right financing sources globally.

Our principals have a combined 50+ years experience of adversing National Governments and Global Multinational Corporations in delivering Socio-economic and sustainable benefits across sectors such as Energy, Infrastructure, Technology and Agriculture.

THINKTALKREALIZE

FOR MORE INFORMATIONCONTACT Us

71 -75 Shelton Street, London WC2H 9JQ :ADDREss

+44 2038731061 :PHONE

[email protected] :Email

WE AREDFS Africa provides expert support to individuals and organizations. We support our clients to implement growth strategy, unlock value from their operations and assets, as well as realize benefits from complex projects.

Our range of investment and business advisory services include:• Project & Infrastructure Financing• Advisory Services to Private Equity

Management Firms• Strategic Advisory Services• Financial Restructuring• Private Placement of Debt and Equity• Merger & Acquisitions Advisory Services• Valuations and Fairness Opinions

OUR COMPANY ON

dfsafrica.org

For sponsorship, partnership or registration enquiries, please contact the DFS team

DFs Africa Ltd.

Address: 71 -75 Shelton Street, London WC2H 9JQ

Telephone: +44 2038731061

Mobile: +44 7877903056 / +44 7850131080

Email: [email protected]

Website: www.dfsafrica.org

africa pharma conference 2020...2020/04/01 · (auc), and key stakeholders including the consortium...

Documents